What does Dyne Therapeutics, Inc. do?
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular…
What is Dyne Therapeutics, Inc.'s P/E and P/B ratio?
Dyne Therapeutics, Inc. has a P/E ratio of -4.8 and a P/B ratio of 4.19.
What is Dyne Therapeutics, Inc.'s debt-to-equity ratio?
Dyne Therapeutics, Inc. has a debt-to-equity ratio of 0.33.
How much does Dyne Therapeutics, Inc. owe compared with what it owns?
Dyne Therapeutics, Inc. owes $0.29 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Dyne Therapeutics, Inc.'s Positivity rank?
Dyne Therapeutics, Inc. is ranked #4,952 of 6,774 companies globally and #2,605 of 4,000 in United States on PositoAI, with a Positivity Score of 18,687.
Does Dyne Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Dyne Therapeutics, Inc..
Where can I read the latest news about Dyne Therapeutics, Inc.?
Recent headlines about Dyne Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Dyne Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Dyne Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.